These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1777726)

  • 1. [Brain imaging: neuropathologic applications to Alzheimer's disease: role of tomodensitometry and endocrine evaluation].
    Leonardi M; Martelli A; Costa A; Mauri M; Zanotti B; Zappoli F
    Bull Assoc Anat (Nancy); 1991 Jun; 75(229):97-9. PubMed ID: 1777726
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine changes in Alzheimer's disease.
    Davidson M; Bastiaens L; Davis BM; Shah MB; Davis KL
    Neurol Clin; 1988 Feb; 6(1):149-57. PubMed ID: 2898094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sundowning syndrome and hypothalamic-pituitary-adrenal axis dysregulation in individuals with Alzheimer's disease: is there an association?
    Venturelli M; Scarsini R; Muti E; Salvagno GL; Schena F
    J Am Geriatr Soc; 2013 Nov; 61(11):2055-6. PubMed ID: 24219216
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis stress test in patients with early RA: role of corticotropin-releasing hormone promoter polymorphisms.
    Malysheva O; Wagner U; Wahle M; Pierer M; Wagner U; Stalla GK; Baerwald CG
    Ann Rheum Dis; 2011 Nov; 70(11):2058-9. PubMed ID: 21666229
    [No Abstract]   [Full Text] [Related]  

  • 5. The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease.
    Swanwick GR; Coen RF; Walsh JB; Coakley D; Lawlor BA
    Biol Psychiatry; 1996 Jun; 39(11):976-8. PubMed ID: 9162211
    [No Abstract]   [Full Text] [Related]  

  • 6. Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease.
    Näsman B; Olsson T; Fagerlund M; Eriksson S; Viitanen M; Carlström K
    Biol Psychiatry; 1996 Mar; 39(5):311-8. PubMed ID: 8704061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
    Hashimoto K; Murakami K; Hattore T; Ota Z
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional state of the hypothalamo-hypophyseo-adrenal system and its correction in shock].
    El'skiĭ VN; Kriuk IuIa; Samsonenko RA; Manankov AK; Akishev AM
    Patol Fiziol Eksp Ter; 1984; (6):83-6. PubMed ID: 6097862
    [No Abstract]   [Full Text] [Related]  

  • 10. [CRH receptor: evaluation of the receptor functions].
    Horiba N; Suda T
    Nihon Rinsho; 1997 Apr; 55 Suppl 2():472-5. PubMed ID: 9172569
    [No Abstract]   [Full Text] [Related]  

  • 11. Endogenous opioids and hypothalamic-pituitary-adrenal function in obesity and anorexia nervosa.
    Cavagnini F; Invitti C; Dubini A; Danesi L; Silvestri G; Passamonti M; Magella A; Morabito F
    Adv Biochem Psychopharmacol; 1987; 43():273-81. PubMed ID: 3035891
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: lack of association between longitudinal and cross-sectional findings.
    Swanwick GR; Kirby M; Bruce I; Buggy F; Coen RF; Coakley D; Lawlor BA
    Am J Psychiatry; 1998 Feb; 155(2):286-9. PubMed ID: 9464214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of the reactions of the hypothalamo-pituitary-adrenal system during stress].
    Viru AA
    Usp Sovrem Biol; 1979; 87(2):271-86. PubMed ID: 222086
    [No Abstract]   [Full Text] [Related]  

  • 14. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

  • 15. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C; Miller GE
    Psychosom Med; 2011; 73(2):114-26. PubMed ID: 21257974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased activity of stress-regulating systems in Alzheimer disease].
    Hoogendijk WJ; Meynen G; Feenstra MG; Eikelenboom P; Kamphorst W; Swaab DF
    Tijdschr Gerontol Geriatr; 2001 Feb; 32(1):17-23. PubMed ID: 11293840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The reaction of the hypothalamo-hypophyseal-adrenal cortex system in rats to unilateral adrenalectomy in hypoparathyroidism].
    Drzhevetskaia IA; Surkhobi ZG; Dzhandarova TI
    Fiziol Zh Im I M Sechenova; 1993 Mar; 79(3):88-93. PubMed ID: 8395944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuroprotective actions of corticotropin releasing hormone.
    Bayatti N; Behl C
    Ageing Res Rev; 2005 May; 4(2):258-70. PubMed ID: 16046283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: pathophysiologic implications.
    Laue L; Gold PW; Richmond A; Chrousos GP
    Adv Pediatr; 1991; 38():287-316. PubMed ID: 1656715
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels.
    Dimopoulou I; Tsagarakis S; Kouyialis AT; Roussou P; Assithianakis G; Christoforaki M; Ilias I; Sakas DE; Thalassinos N; Roussos C
    Crit Care Med; 2004 Feb; 32(2):404-8. PubMed ID: 14758155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.